Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness

Covid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward patho...

Full description

Bibliographic Details
Main Authors: Camilla Tincati, E. Stefania Cannizzo, Mauro Giacomelli, Raffaele Badolato, Antonella d’Arminio Monforte, Giulia Marchetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/full
id doaj-e853cf9a95884293b1c10cb7a2f23d8c
record_format Article
spelling doaj-e853cf9a95884293b1c10cb7a2f23d8c2020-11-25T03:08:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.580987580987Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of IllnessCamilla Tincati0E. Stefania Cannizzo1Mauro Giacomelli2Raffaele Badolato3Antonella d’Arminio Monforte4Giulia Marchetti5Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, ASST Spedali Civili and A. Nocivelli Institute of Molecular Medicine, c/o Spedali Civili, Brescia, ItalyDipartimento di Scienze Cliniche e Sperimentali, Università degli Studi di Brescia, ASST Spedali Civili and A. Nocivelli Institute of Molecular Medicine, c/o Spedali Civili, Brescia, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyDepartment of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, ItalyCovid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward pathogenic versus protective inflammatory responses. Subjects with either severe (s; PaO2/FiO2 ratio <200) or mild (m; PaO2/FiO2 ratio>300) Covid-19 were enrolled. A range of chemokines and cytokines as well as reactive oxygen species (ROS) were measured in plasma. Dendritic and NK cell frequency, monocyte and B-/T-cell phenotype and SARS-CoV-2-specific T-cell responses were assessed in PBMC. Twenty mCovid-19 and 20 sCovid-19 individuals were studied. sCovid-19 patients displayed higher non-classical monocytes, plasma chemokines (CXCL8, CXCL9, CXCL10), cytokines (IL-6, IL-10), and ROS versus mCovid-19. sCovid-19 also showed significantly increased activated CD38+HLA-DR+ T-lymphocyte, and granzyme-B+/perforin+ pro-cytolytic T-cells. All Covid-19 patients showed SARS-CoV-2 specific-T-cell response with a predominance of Th1 bi- or trifunctional IFN-γ/IL-2/TNF-α-expressing CD4+, while no difference according to disease severity was observed. Severe Covid-19 features heightened circulating IFN-inducible chemokines and activated pro-cytolytic Th1 cell phenotype in the second week of illness, yet SARS-CoV-2-specific responses are similar to that of mild illness. Altogether, our observations suggest Th1 polarization coupled to higher cytolytic profile in sCovid-19 as correlate of disease pathogenesis and as potential targets to be investigated in the roadmap to therapy and vaccine development.https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/fullCovid-19SARS-CoV-2immunityS/M/N protein-reactive T-cellsimmunopathology
collection DOAJ
language English
format Article
sources DOAJ
author Camilla Tincati
E. Stefania Cannizzo
Mauro Giacomelli
Raffaele Badolato
Antonella d’Arminio Monforte
Giulia Marchetti
spellingShingle Camilla Tincati
E. Stefania Cannizzo
Mauro Giacomelli
Raffaele Badolato
Antonella d’Arminio Monforte
Giulia Marchetti
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
Frontiers in Immunology
Covid-19
SARS-CoV-2
immunity
S/M/N protein-reactive T-cells
immunopathology
author_facet Camilla Tincati
E. Stefania Cannizzo
Mauro Giacomelli
Raffaele Badolato
Antonella d’Arminio Monforte
Giulia Marchetti
author_sort Camilla Tincati
title Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
title_short Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
title_full Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
title_fullStr Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
title_full_unstemmed Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
title_sort heightened circulating interferon-inducible chemokines, and activated pro-cytolytic th1-cell phenotype features covid-19 aggravation in the second week of illness
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-10-01
description Covid-19 features a delayed onset of critical illness occurring approximately one week from the beginning of symptoms, which corresponds to the bridging of innate and adaptive immunity. We reasoned that the immune events occurring at the turning point of disease might mark the direction toward pathogenic versus protective inflammatory responses. Subjects with either severe (s; PaO2/FiO2 ratio <200) or mild (m; PaO2/FiO2 ratio>300) Covid-19 were enrolled. A range of chemokines and cytokines as well as reactive oxygen species (ROS) were measured in plasma. Dendritic and NK cell frequency, monocyte and B-/T-cell phenotype and SARS-CoV-2-specific T-cell responses were assessed in PBMC. Twenty mCovid-19 and 20 sCovid-19 individuals were studied. sCovid-19 patients displayed higher non-classical monocytes, plasma chemokines (CXCL8, CXCL9, CXCL10), cytokines (IL-6, IL-10), and ROS versus mCovid-19. sCovid-19 also showed significantly increased activated CD38+HLA-DR+ T-lymphocyte, and granzyme-B+/perforin+ pro-cytolytic T-cells. All Covid-19 patients showed SARS-CoV-2 specific-T-cell response with a predominance of Th1 bi- or trifunctional IFN-γ/IL-2/TNF-α-expressing CD4+, while no difference according to disease severity was observed. Severe Covid-19 features heightened circulating IFN-inducible chemokines and activated pro-cytolytic Th1 cell phenotype in the second week of illness, yet SARS-CoV-2-specific responses are similar to that of mild illness. Altogether, our observations suggest Th1 polarization coupled to higher cytolytic profile in sCovid-19 as correlate of disease pathogenesis and as potential targets to be investigated in the roadmap to therapy and vaccine development.
topic Covid-19
SARS-CoV-2
immunity
S/M/N protein-reactive T-cells
immunopathology
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.580987/full
work_keys_str_mv AT camillatincati heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
AT estefaniacannizzo heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
AT maurogiacomelli heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
AT raffaelebadolato heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
AT antonelladarminiomonforte heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
AT giuliamarchetti heightenedcirculatinginterferoninduciblechemokinesandactivatedprocytolyticth1cellphenotypefeaturescovid19aggravationinthesecondweekofillness
_version_ 1724667721551970304